Oncology Research Veterans Launch TrialNAV
TrialNAV, a clinical research solutions company designed to bridge the gaps between industry sponsors, research sites, and cancer trial participants has announced its launch. The company's suite of offerings will offer solutions for the identified challenges in the pharmaceutical and technology industries, clinical research organizations, site management organizations, and clinical research sites within healthcare organizations. The solutions are designed to improve enrollment in clinical research and provide better access to treatment options for people living with cancer.
Read more about the launch here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
